Categories AlphaGraphs, Earnings, Technology

Infographic: Facebook (FB) Q3 revenue up 35%, earnings beat estimates

Social media behemoth Facebook, Inc. (NASDAQ: FB) on Monday said its third-quarter revenues and earnings increased sharply, aided by strong demand from advertisers. Earnings also topped expectations. The stock made strong gains in extended trading immediately after the announcement.

Facebook Q3 2021 earnings infographic

Revenues jumped 35% to $29.0 billion in the third quarter, with most of it coming from the core advertising segment. Analysts had forecast a faster growth. The top-line benefited from a 6% increase in daily active users. At the end of the quarter, the company had 2.91 billion monthly active users.

Reflecting the strong revenue growth, net profit climbed to $9.19 billion or $3.22 per share from $7.84 billion or $2.71 per share in the third quarter of 2020. Earnings also exceeded the market’s projection.


Read management/analysts’ comments on Facebook’s Q3 2021 earnings


Facebook’s stock has grown 22% since the beginning of 2021. It closed Monday’s trading higher and gained further in the after-hours session following the earnings release.

Prior Performance

  • Facebook Q2 2021 earnings
  • Facebook Q1 2021 earnings
  • FACEBOOK Q4 2020 earnings
  • Facebook Q3 2020 earnings

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

HP Inc. (HPQ) stock research summary | Q3 2021

HP Inc has shown a strong performance in Q4 2021. In spite of remote working, HP has shown a strong demand for PC and printer. The company has beat Zacks

VMware Inc. (VMW) stock research summary | Q3 2021

In this era of digital transformation, the technology industry is seeing a rapid influx of innovative products and solutions that help businesses adapt to the fast-changing and complex environment. VMware

IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a record year though the rush led by the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top